F45.2
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Main diagnosis: Body dysmorphic disorder - At least a score of 14 in the Questionnaire Body Dysmorphic Symptoms (FKS)
Exclusion criteria
Exclusion criteria: - Current psychotherapy (outpatient/residential/inpatient) - Cognitive-behavioral treatment of the body dysmorphic disorder in the last 6 months - Instable psychopharmacological medication in the last 2 months - Severe or acute suicidality - Acute substance dependence, current severe depression, bipolar disorder, diagnosed schizophrenia or borderline personality disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measurement of symptom severity through a semi-structured clinical interview: Yale-Brown Obsessive-Compulsive Scale Modified for Body Dysmorphic Disorder (BDD-YBOCS) Assessment points: Baseline, Post-Treatment (both arms) Measurement of symptom severity through a self-report questionnaire: Questionnaire Body Dysmorphic Symptoms (FKS) Assessment points: Baseline, Post-Treatment (both arms), at Follow-up (one month after treatment, both arms) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Secondary BDD psychopathology: Dysmorphic Concerns Questionnaire (DCQ), List of Safety Behaviors (LSB), German version of the Physical Appearance Comparison Scale (PACS) Brown Assessment of Beliefs Scale in Body Dysmorphic Disorder (BABS; interview) Mirror Gazing Questionnaire (MGQ) Questionnaire Body Dysmorphic Cognitions (FKDK) 2. General psychopathology: General affect using The affect scale Depressive symptoms using the Patient Health Questionnaire (PHQ-9) Rumination using the Screening-Instrument of Rumination-Suppression (RS-8) Social anxiety symptoms using the Questionnaire on Social Anxiety and Deficits in Social Competences – Adolescents Version (SASKO-J) Eating disorder symptoms using the Eating Disorder Examination Questionnaire 8 (EDE-Q8) Obsessive compulsive symptoms using the Obsessive-Compulsive Inventory-Revised (OCI-R) Self-esteem using the Multimodal Self-Esteem Scale (MSES) Suicidal ideation and plans using the suicide items of the Beck Depression Inventory (BDI-II) 3. Other areas of experiencing Quality of Life using the Questionnaire on Quality of Life in Children and Adolescents – Revised Version (KINDL-R) Self-efficacy using the Scale for Perceived Self-Efficacy (SWE) 4. Aversive events 5. Program evaluation: Acceptance using the Credibility and Expectancy questionnaire (CEQ) and the Message Credibility Scale (MCS) Patient Satisfaction using the Questionnaire for the Assessment of Patient Satisfaction (ZUF-8) 6. Other instrumente / mediators: Technology Affinity Questionnaire (TAEG) Working Alliance Inventory – short revised (WAI-SR) Comorbid mental disorders: Short Diagnostic Interview of Mental Disorders(Mini-DIPS) | — |
Countries
Austria, Germany, Switzerland
Contacts
Universität Osnabrück, Institut für Psychologie, Klinische Psychologie und Psychotherapie